Pnc Financial Services Group, Inc. Bio Rad Laboratories, Inc. Transaction History

Pnc Financial Services Group, Inc.

  • $190 Billion
  • Q1 2025

A detailed history of Pnc Financial Services Group, Inc. transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 3,350 shares of BIO stock, worth $767,652. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,350
Previous 8,502 60.6%
Holding current value
$767,652
Previous $2.79 Million 70.81%
% of portfolio
0.0%
Previous 0.0%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 09, 2025
SELL
$243.0 - $367.0 $1.25 Million - $1.89 Million
-5,152 Reduced 60.6%
3,350 $815,000
Q4 2024

Feb 07, 2025
SELL
$313.15 - $374.28 $79,226 - $94,692
-253 Reduced 2.89%
8,502 $2.79 Million
Q3 2024

Nov 08, 2024
BUY
$263.97 - $344.64 $209,856 - $273,988
795 Added 9.99%
8,755 $2.93 Million
Q2 2024

Aug 09, 2024
SELL
$268.26 - $339.48 $477,771 - $604,613
-1,781 Reduced 18.28%
7,960 $2.17 Million
Q1 2024

May 10, 2024
SELL
$304.11 - $351.99 $47,441 - $54,910
-156 Reduced 1.58%
9,741 $3.37 Million
Q4 2023

Feb 09, 2024
SELL
$269.37 - $365.04 $287,687 - $389,862
-1,068 Reduced 9.74%
9,897 $3.2 Million
Q3 2023

Nov 13, 2023
SELL
$350.25 - $422.63 $24,167 - $29,161
-69 Reduced 0.63%
10,965 $3.93 Million
Q2 2023

Aug 11, 2023
SELL
$359.49 - $486.4 $68,662 - $92,902
-191 Reduced 1.7%
11,034 $4.18 Million
Q1 2023

May 15, 2023
BUY
$418.69 - $503.0 $30,564 - $36,719
73 Added 0.65%
11,225 $5.38 Million
Q4 2022

Feb 10, 2023
BUY
$351.71 - $456.01 $177,261 - $229,829
504 Added 4.73%
11,152 $4.69 Million
Q3 2022

Nov 10, 2022
BUY
$412.59 - $563.26 $29,293 - $39,991
71 Added 0.67%
10,648 $4.44 Million
Q2 2022

Aug 12, 2022
SELL
$463.67 - $597.16 $43,584 - $56,133
-94 Reduced 0.88%
10,577 $5.24 Million
Q1 2022

May 12, 2022
SELL
$524.57 - $735.42 $398,673 - $558,919
-760 Reduced 6.65%
10,671 $6.01 Million
Q4 2021

Feb 11, 2022
BUY
$708.84 - $794.68 $3.19 Million - $3.58 Million
4,504 Added 65.02%
11,431 $8.64 Million
Q3 2021

Nov 05, 2021
BUY
$657.71 - $825.77 $92,079 - $115,607
140 Added 2.06%
6,927 $5.17 Million
Q2 2021

Aug 06, 2021
SELL
$576.64 - $649.04 $24,795 - $27,908
-43 Reduced 0.63%
6,787 $4.37 Million
Q1 2021

May 07, 2021
BUY
$547.01 - $662.35 $23,521 - $28,481
43 Added 0.63%
6,830 $3.9 Million
Q4 2020

Feb 12, 2021
SELL
$510.68 - $643.45 $154,225 - $194,321
-302 Reduced 4.26%
6,787 $3.96 Million
Q3 2020

Nov 06, 2020
SELL
$454.43 - $535.6 $28,629 - $33,742
-63 Reduced 0.88%
7,089 $3.65 Million
Q2 2020

Aug 07, 2020
SELL
$334.87 - $493.06 $258,184 - $380,149
-771 Reduced 9.73%
7,152 $3.23 Million
Q1 2020

May 08, 2020
SELL
$320.01 - $409.07 $72,642 - $92,858
-227 Reduced 2.79%
7,923 $2.78 Million
Q4 2019

Feb 07, 2020
BUY
$319.73 - $374.2 $54,034 - $63,239
169 Added 2.12%
8,150 $3.02 Million
Q3 2019

Nov 08, 2019
BUY
$304.55 - $345.24 $304 - $345
1 Added 0.01%
7,981 $2.66 Million
Q2 2019

Aug 09, 2019
SELL
$286.93 - $312.59 $136,578 - $148,792
-476 Reduced 5.63%
7,980 $0
Q1 2019

May 10, 2019
SELL
$224.3 - $317.41 $448 - $634
-2 Reduced 0.02%
8,456 $0
Q4 2018

Feb 08, 2019
BUY
$220.1 - $309.0 $35,876 - $50,367
163 Added 1.97%
8,458 $1.96 Million
Q3 2018

Nov 09, 2018
BUY
$289.28 - $326.15 $18,224 - $20,547
63 Added 0.77%
8,295 $0
Q2 2018

Aug 10, 2018
BUY
$244.1 - $303.88 $117,168 - $145,862
480 Added 6.19%
8,232 $0
Q1 2018

May 11, 2018
BUY
$233.97 - $274.11 $326,622 - $382,657
1,396 Added 21.96%
7,752 $0
Q4 2017

Feb 09, 2018
SELL
$216.94 - $271.3 $17,355 - $21,704
-80 Reduced 1.24%
6,356 $0
Q3 2017

Nov 13, 2017
BUY
$212.27 - $242.28 $1.37 Million - $1.56 Million
6,436
6,436 $0

Others Institutions Holding BIO

# of Institutions
462
Shares Held
18.9M
Call Options Held
12.7K
Put Options Held
14.4K
View Full List

About BIO-RAD LABORATORIES, INC.

BIO Quotes by TradingView
  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $5.64B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Pnc Financial Services Group, Inc. Portfolio

Follow Pnc Financial Services Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email